Bone Loss Terminated Phase Trials for Zoledronic acid (DB00399)

Back to Bone Loss

Also known as: Osteopenia / Osteopenia (disorder) / Osteopenia (morphologic abnormality) / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01623908Bone Loss Treatment From Adjuvant Zoledronate EfficacyTreatment